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A corrigendum on
Commentary: Evaluation of Models of Parkinson’s Disease
by Muñoz, P., Paris, I., and Segura-Aguilar, J. (2016). Front. Neurosci. 10:161. doi:
10.3389/fnins.2016.00161
It was an error in the structure of dopamine o-quinone published in the commentary on Evaluation
of models of Parkinson’s disease since the benzene ring contained an extra double bound between
the carbonyls. The actual structure of dopamine o-quinone is the correct structure.
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FIGURE 1 | Astrocytes protect dopaminergic neurons against aminochrome neurotoxicity. Astrocytes secrete GSTM2 which is internalized by dopaminergic
neurons in order to increase their protection against aminochrome. Dopamine oxidation to neuromelanin is a harmless pathway due to the presence of DT-diaphorase
and GSTM2 that prevent aminochrome-dependent neurotoxicity by inhibiting the formation of alpha-synuclein (SNCA) neurotoxic oligomers, mitochondrial
dysfunction, oxidative stress, autophagy, and proteasome dysfunction and endoplasmic reticulum stress.
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